AccessPak for HIV PEP Expanded with Kaletra and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Tafenoquine Succinate (Arakoda)
- AccessPak for HIV PEP Expanded with Kaletra-Tafenoquine Succinate (Krintafel)
- AccessPak for HIV PEP Expanded with Kaletra-Tafinlar
- AccessPak for HIV PEP Expanded with Kaletra-Tafluprost
- AccessPak for HIV PEP Expanded with Kaletra-Tafluprost ophthalmic
- AccessPak for HIV PEP Expanded with Kaletra-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-AccessPak for HIV PEP Expanded with Viracept
- Tafenoquine (Prevention of Malaria Relapse)-Accolate
- Tafenoquine (Prevention of Malaria Relapse)-Accretropin
- Tafenoquine (Prevention of Malaria Relapse)-Accucaine
- Tafenoquine (Prevention of Malaria Relapse)-AccuHist Drops
- Tafenoquine (Prevention of Malaria Relapse)-AccuHist PDX Drops